W

ASHINGTON — After months of pledging he would get pharmaceutical companies to lower their prices, President Trump can now say that he pressed the CEO of a major drug maker, Pfizer, to back down on a series of price hikes.

Pfizer, in turn, has earned glowing praise from Trump and his administration and will likely not suffer much, if at all, financially.

Unlock this article by subscribing to STAT Plus. Try it FREE for 30 days!

SUBSCRIBE TODAY

What is it?

STAT Plus is a premium subscription that delivers daily market-moving biopharma coverage and in-depth science reporting from a team with decades of industry experience.

What's included?

  • Authoritative biopharma coverage and analysis, interviews with industry pioneers, policy analysis, and first looks at cutting edge laboratories and early stage research
  • Subscriber-only networking events and panel discussions across the country
  • Monthly subscriber-only live chats with our reporters and experts in the field
  • Discounted tickets to industry events and early-bird access to industry reports

Leave a Comment

Please enter your name.
Please enter a comment.

  • I guess in his world, and mind, a delayed increase in prices amounts to a huge drop in the cost of drugs. So, promise kept!
    There is also a chance he is a HUGE fan of the godfather and goodfellas movies, so he made them an offer they couldn’t refuse and it would be a shame something would happen to Pfizer CEO’s family. Capisc?

  • It looks like people are accustomed to the Alternative Facts. This will be spun by the media to make it appear he cured cancer.

Sign up for our Morning Rounds newsletter

Your daily dose of what’s new in health and medicine.

Privacy Policy